| Abilify 1 mg/mL oral solution EU/1/04/276/033-035 |
Aripiprazole |
Otsuka Pharmaceutical Netherlands B.V. |
— |
| Abilify 10 mg orodispersible tablets EU/1/04/276/024-026 |
Aripiprazole |
Otsuka Pharmaceutical Netherlands B.V. |
— |
| Abilify 10 mg tablets EU/1/04/276/006-010 |
Aripiprazole |
Otsuka Pharmaceutical Netherlands B.V. |
— |
| Abilify 15 mg orodispersible tablets EU/1/04/276/027-029 |
Aripiprazole |
Otsuka Pharmaceutical Netherlands B.V. |
— |
| Abilify 15 mg tablets EU/1/04/276/011-015 |
Aripiprazole |
Otsuka Pharmaceutical Netherlands B.V. |
— |
| Abilify 30 mg orodispersible tablets EU/1/04/276/030-032 |
Aripiprazole |
Otsuka Pharmaceutical Netherlands B.V. |
— |
| Abilify 30 mg tablets EU/1/04/276/016-020 |
Aripiprazole |
Otsuka Pharmaceutical Netherlands B.V. |
— |
| Abilify 5 mg tablets EU/1/04/276/001-005 |
Aripiprazole |
Otsuka Pharmaceutical Netherlands B.V. |
— |
| Abilify 7.5 mg/mL solution for injection EU/1/04/276/036 |
Aripiprazole |
Otsuka Pharmaceutical Netherlands B.V. |
— |
| Abilify Maintena 300 mg powder and solvent for prolonged-release suspension for injection EU/1/13/882/001,003 |
Aripiprazole |
Otsuka Pharmaceutical Netherlands B.V. |
— |
| Abilify Maintena 400 mg powder and solvent for prolonged-release suspension for injection EU/1/13/882/002,004 |
Aripiprazole |
Otsuka Pharmaceutical Netherlands B.V. |
— |
| Abilify Maintena 720 mg prolonged-release suspension for injection in pre-filled syringe EU/1/13/882/009 |
Aripiprazole Monohydrate |
Otsuka Pharmaceutical Netherlands B.V. |
— |
| Abilify Maintena 960 mg prolonged-release suspension for injection in pre-filled syringe EU/1/13/882/010 |
Aripiprazole Monohydrate |
Otsuka Pharmaceutical Netherlands B.V. |
— |
| ASACARD 162.5 mg prolonged release hard capsules PA1966/001/001 |
Acetylsalicylic acid |
New Haven Pharma (UK) Limited |
Not marketed |
| BRUKINSA 160 mg film-coated tablets EU/1/21/1576/002 |
Zanubrutinib |
BeiGene Ireland Limited |
— |
| BRUKINSA 80 mg hard capsules EU/1/21/1576/001 |
Zanubrutinib |
BeiGene Ireland Limited |
— |
| Chamomilla - Tablets HOR0407/018/001 |
Chamomilla recutita |
Weleda (UK) Limited |
— |
| Cosentyx 150 mg Powder for solution for injection EU/1/14/980/001 |
Secukinumab |
Novartis Europharm Limited |
— |
| Cosentyx 150 mg Solution for injection pre-filled pen EU/1/14/980/004-005 |
Secukinumab |
Novartis Europharm Limited |
— |
| Cosentyx 150 mg Solution for injection pre-filled syringe EU/1/14/980/002-003 |
Secukinumab |
Novartis Europharm Limited |
— |
| Cosentyx 300 mg Solution for injection in pre-filled pen EU/1/14/980/10-011 |
Secukinumab |
Novartis Europharm Limited |
— |
| Cosentyx 300 mg Solution for injection in pre-filled syringe EU/1/14/980/008-009 |
Secukinumab |
Novartis Europharm Limited |
— |
| Cosentyx 75 mg Solution for injection pre-filled syringe EU/1/14/980/012-013 |
Secukinumab |
Novartis Europharm Limited |
— |
| Dawnzera 80mg solution for injection in pre-filled pen EU/1/25/2001/001-002 |
Donidalorsen sodium |
Otsuka Pharmaceutical Netherlands B.V. |
— |
| Deltyba EU/1/13/875/001-003 |
Delamanid |
Otsuka Novel Products GmbH |
— |
| Deltyba 25 mg dispersible tablets EU/1/13/875/005 |
Delamanid |
Otsuka Novel Products GmbH |
— |
| DUKORAL EU/1/03/263/1-3 |
Cholera vaccine |
Crucell Sweden AB |
Marketed |
| Fluarix Tetra suspension for injection in pre-filled syringe Influenza vaccine (split virion, inactivated) PA1077/134/001 |
A/Victoria/4897/2022 (H1N1)pdm09-like strain (A/Victoria/4897/2022, IVR-238, A/Darwin/9/2021 (H3N2)-like strain (A/Darwin/6/2021, IVR-227), B/Austria/1359417/2021 - like strain (B/Austria/1359417/2021, BVR-26) [Victoria lineage], B/PHUKET/3073/2013 -LIKE STRAIN (B/PHUKET/3073/2013, WILD TYPE) |
GlaxoSmithKline (Ireland) Limited |
Not marketed |
| Hukyndra 20 mg solution for injection in pre-filled syringe EU/1/21/1589/010 |
Adalimumab |
Stada Arzneimittel AG |
— |
| Hukyndra 40 mg solution for injection in pre-filled pen EU/1/21/1589/004-006 |
Adalimumab |
Stada Arzneimittel AG |
— |
| Hukyndra 40 mg solution for injection in pre-filled syringe EU/1/21/1589/001-003 |
Adalimumab |
Stada Arzneimittel AG |
— |
| Hukyndra 80 mg solution for injection in pre-filled pen EU/1/21/1589/008-009 |
Adalimumab |
Stada Arzneimittel AG |
— |
| Hukyndra 80 mg solution for injection in pre-filled syringe EU/1/21/1589/007 |
Adalimumab |
Stada Arzneimittel AG |
— |
| Inaqovi 35 mg/100 mg film-coated tablets EU/1/23/1756/001 |
Decitabine, Cedazuridine |
Otsuka Pharmaceutical Netherlands B.V. |
— |
| Influvac Tetra, suspension for injection in pre-filled syringe (influenza vaccine, surface antigen, inactivated) PA23355/016/001 |
A/Victoria/2570/2019 (H1N1)pdm09 - like strain (A/Victoria/2570/2019, IVR-215), B/PHUKET/3073/2013 -LIKE STRAIN (B/PHUKET/3073/2013, WILD TYPE), B/Austria/1359417/2021 - like strain (B/Michigan/01/2021, wild type), Influenza A virus, A/Croatia/10136RV/2023 (H3N2) like strain X-425A, Inactivated |
Viatris Healthcare Limited |
Not marketed |
| Jinarc 15 mg tablets EU/1/15/1000/001-002 |
Tolvaptan |
Otsuka Pharmaceutical Netherlands B.V. |
— |
| Jinarc 15 mg tablets + Jinarc 45 mg tablets EU/1/15/1000/005-007 |
Tolvaptan |
Otsuka Pharmaceutical Netherlands B.V. |
— |
| Jinarc 30 mg tablets EU/1/15/1000/003-004 |
Tolvaptan |
Otsuka Pharmaceutical Netherlands B.V. |
— |
| Jinarc 30 mg tablets + Jinarc 60 mg tablets EU/1/15/1000/008-010 |
Tolvaptan |
Otsuka Pharmaceutical Netherlands B.V. |
— |
| Jinarc 30 mg tablets + Jinarc 90 mg tablets EU/1/15/1000/011-013 |
Tolvaptan |
Otsuka Pharmaceutical Netherlands B.V. |
— |
| Leukeran 2 mg film-coated tablets PA1691/007/001 |
Chlorambucil |
Aspen Pharma Trading Limited |
Marketed |
| Lupkynis 7.9 mg soft capsules EU/1/22/1678/001 |
Voclosporin |
Otsuka Pharmaceutical Netherlands B.V. |
— |
| Montelair 10 mg Film-coated Tablets PA0126/215/003 |
Montelukast |
Clonmel Healthcare Ltd |
Marketed |
| Montelair 4 mg Chewable Tablets PA0126/215/001 |
Montelukast |
Clonmel Healthcare Ltd |
Marketed |
| Montelair 5 mg Chewable Tablets PA0126/215/002 |
Montelukast |
Clonmel Healthcare Ltd |
Marketed |
| Montelukast 10 mg film-coated tablets PA1347/039/003 |
Montelukast |
KRKA, d.d., Novo mesto |
Marketed |
| Montelukast 10 mg film-coated tablets PA2315/110/003 |
Montelukast |
Accord Healthcare Ireland Ltd. |
Marketed |
| MONTELUKAST 10 mg Film-Coated Tablets PA1445/015/001 |
Montelukast sodium |
Aurobindo Pharma (Malta) Limited |
Not marketed |
| Montelukast 4 mg chewable tablets PA1347/039/001 |
Montelukast |
KRKA, d.d., Novo mesto |
Marketed |
| Montelukast 5 mg chewable tablets PA1347/039/002 |
Montelukast |
KRKA, d.d., Novo mesto |
Marketed |